ERBB2 and neoplasm: The molecular classification in this study did not include the current clinical parameters like tumour grade, steroid receptor status, and HER-2/neu. In essence, there may be more clusters and molecular subtypes of breast cancer that may be apparent if larger sample sets are available (McShane et al, 2002).